COVID-19 Research Paper Volume 12, Issue 9 pp 7639—7651

Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2

Figure 3. The interferon variation trend after SARS-CoV treatment 12h, 24h and 48h respectively. (A) IFN-α2; (B) IFN-β1; (C) IFN-2.